Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06656533 · ClinicalTrials.gov registry record · NA

Optimizing the Timing of rTMS to Enhance the Administration of Insomnia Treatment

A NA study, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
10
Enrollment target

NCT06656533: Recruiting NA study, sponsored by Stanford University.

NCT06656533 is a NA study that is actively recruiting participants, run by Stanford University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06656533, a NA study, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Repetitive transcranial magnetic stimulation (rTMS) has shown to be a promising technique for improving insomnia symptoms and sleep quality. However, the impact of circadian rhythmicity on rTMS sessions and its potential influence on insomnia therapy remains unclear. Moreover, the effect of rTMS on objective sleep parameters is not fully established. The objective of this pilot study is to establish key feasibility and preliminary data that would be used for an R-level grant application focused on optimizing rTMS therapy for insomnia. The investigators will acquire feasibility data from ten adults with Insomnia disorder. Participants will receive ten sessions rTMS over two weeks, either in the morning or evening. Sleep parameters will be assessed before, during, and after completion of rTMS and brain cortical excitability will be collected before rTMS treatment. The investigators aim to 1) evaluate the impact of circadian timing of rTMS sessions on subjective and objective sleep outcomes, 2) assess the time course of improvements in sleep outcomes, and 3) examine the association between sleep outcomes and cortical excitability. The overarching goal of this work is to optimize rTMS therapy for insomnia by investigating the impact of circadian timing on rTMS sessions and assessing potential variations in subjective and objective measures of sleep.

Interventions

  • OTHER Repeated Transcranial magnetic stimulation (rTMS)

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-03-01
Est. Completion 2026-09-30
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT06656533

The ClinicalTrials.gov registry entry for NCT06656533 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Repeated Transcranial magnetic stimulation (rTMS) is the first listed.

NCT06656533 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06656533 about?

NCT06656533 is a clinical study titled "Optimizing the Timing of rTMS to Enhance the Administration of Insomnia Treatment". Repetitive transcranial magnetic stimulation (rTMS) has shown to be a promising technique for improving insomnia symptoms and sleep quality. However, the impact of circadian rhythmicity on rTMS sessions and its potential influence on insomnia therapy remains unclear. Moreover, the effect of rTMS on ...

What is the current status of trial NCT06656533?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-03-01. Estimated completion is 2026-09-30.

What interventions are being tested in trial NCT06656533?

The interventions under investigation include: Repeated Transcranial magnetic stimulation (rTMS) (OTHER).

Who is sponsoring clinical trial NCT06656533?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.